Notably, melatonin analogs contribute to the restoration of mitophagy and amelioration of behavioral abnormalities associated with cognitive deficits through the activation of the AMPK/PINK1 signaling pathway, which offers a new potential strategy for the treatment of depression [93]. The gene discussed is PINK1; the disease is depressive symptom measurement.